Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Harvard Business School
Boehringer Ingelheim
AstraZeneca
Mallinckrodt

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for AGN-2979

See Plans and Pricing

« Back to Dashboard

Drug Development Status for AGN-2979: Sponsors, patents, clinical trial progress

AGN-2979 is an investigational drug.

There have been 47 clinical trials for AGN-2979. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2014.

The most common disease conditions in clinical trials are Erythema, Dry Eye Syndromes, and Macular Degeneration. The leading clinical trial sponsors are Allergan, Editas Medicine, Inc., and Naurex, Inc, an affiliate of Allergan plc.

There are five US patents protecting this investigational drug and sixty-four international patents.

Recent Clinical Trials for AGN-2979
TitleSponsorPhase
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye DiseaseAllerganPhase 1/Phase 2
AGN-151586 Dose-Ranging Study for Treatment of Glabellar LinesAllerganPhase 2
Single Ascending Dose Study in Participants With LCA10Editas Medicine, Inc.Phase 1/Phase 2

See all AGN-2979 clinical trials

Clinical Trial Summary for AGN-2979

Top disease conditions for AGN-2979
Top clinical trial sponsors for AGN-2979

See all AGN-2979 clinical trials

US Patents for AGN-2979

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
AGN-2979   See Pricing Process for the preparation of 3-aryl-3-aminoalkyl-2,6-dioxohexahydropyridines G. D. Searle & Co. (Chicago, IL)   See Pricing
AGN-2979   See Pricing Memory-enhancing compositions containing dioxopiperidine derivatives National Research Development Corporation (London, GB2)   See Pricing
AGN-2979   See Pricing Process for the preparation of diethyl 2-]2-cyano-5-(dimethylamino)-2-(3-methoxyphenyl)-1,1-dimethylpentyl]prop andioate G. D. Searle & Co. (Chicago, IL)   See Pricing
AGN-2979   See Pricing Piperidin-2,6-dione bisulphate salts and their use for the treatment of stress related affective disorders Prestwick Pharmaceuticals, Inc. (Washington, DC)   See Pricing
AGN-2979   See Pricing Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders Prestwick Pharmaceuticals, Inc. (Washington, DC)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for AGN-2979

Drugname Country Document Number Estimated Expiration Related US Patent
AGN-2979 Canada 2036968 2010-02-27   See Pricing
AGN-2979 European Patent Office 0448972 2010-02-27   See Pricing
AGN-2979 Ireland 910656 2010-02-27   See Pricing
AGN-2979 Japan H04211657 2010-02-27   See Pricing
AGN-2979 Japan H0694460 2010-02-27   See Pricing
AGN-2979 Portugal 96883 2010-02-27   See Pricing
AGN-2979 Austria 79754 2008-11-10   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
McKinsey
Colorcon
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.